Al's Comment:

 Great news!  This is one of my favorite experimental treatments.  Fast track designation will speed up the approval process!

 


Posted on: 12/26/2017

DelMar Pharmaceuticals announces Fast Track designation for VAL-083 in recurrent Glioblastoma

 


Click HERE to return to brain tumor news headlines.


Our privacy / cookie policy has changed.
Click HERE to read it!